Pancreatic cancer trials in Germany
53 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingTrial-stage medicine
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Hamburg, Heilbronn, Muenchen, Munich, Riesa
- Age
- 18 years and over
- People
- 570 worldwide
- Run by
- Immuneering Corporation
See details and how to joinNCT07562152EU 2026-525617-31-00Registry updated 2026-11-06
Phase 1RecruitingTrial-stage medicine
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Where
- Essen
- Age
- 18 years and over
- People
- 340 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07213791EU 2025-521887-37-00Registry updated 2026-11-04
Phase 2RecruitingTrial-stage medicine
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Where
- Hamburg, Heidelberg, Leipzig, Mainz, München, Würzburg
- Age
- 18 years and over
- People
- 254 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07492680Registry updated 2026-11-04
Phase 2RecruitingTrial-stage medicine
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Berlin, Düsseldorf, Freiburg im Breisgau, München, Würzburg
- Age
- 12 years and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075EU 2023-504853-11-00Registry updated 2026-11-03
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Where
- Aachen, Bad Saarow, Berlin, Bochum, Dresden, Duesseldorf, Frankfurt am Main, Hamburg, Hanover, Leipzig, Magdeburg, Mainz, Mannheim, Muenster, Munich, Regensburg, Saarbruecken, Ulm, Wuerzburg
- Age
- 18 years and over
- People
- 614 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07409272EU 2025-523684-38-00Registry updated 2026-11-03
Phase 2/3RecruitingTrial-stage medicine
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Berlin, Erlangen, Essen, Mainz, Marburg, Tübingen, Würzburg
- Age
- 18 years and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755EU 2025-521043-20-00Registry updated 2026-10-30
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- Berlin, Bochum, Bonn, Cologne, Dresden, Düsseldorf, Essen, Frankfurt, Freiburg im Breisgau, Göttingen, Halle, Hamburg, Leipzig, München, Munich, Nuremberg, Ulm
- Age
- 18 years and over
- People
- 588 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07522073Registry updated 2026-10-30
No phaseRecruitingResearch participation
Pancreatic Cancer Early Detection Consortium
- Where
- Essen
- Age
- 18 years to 90 years
- People
- 20,000 worldwide
- Run by
- Arbor Research Collaborative for Health
See details and how to joinNCT04970056Registry updated 2026-10-29
Phase 1/2RecruitingTrial-stage medicine
BOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours
- Where
- Bonn, Ulm
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Bold Therapeutics, Inc.
See details and how to joinNCT04421820EU 2024-517500-11-00Registry updated 2026-10-28
Phase 2RecruitingTrial-stage medicine
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Frankfurt
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478EU 2023-507641-29-00Registry updated 2026-10-26
Phase 1/2RecruitingTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Berlin, Dresden, Heidelberg, Heilbronn, Leipzig, Mainz, Muenster
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064EU 2023-509632-26-00Registry updated 2026-10-26
Phase 3RecruitingTrial-stage medicine
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Where
- Berlin, Frankfurt am Main, Heidelberg, Luebeck, Munich, Ulm
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07252232EU 2025-523495-23-00Registry updated 2026-10-23
Phase 3RecruitingResearch participation
A study to evaluate the efficacy of oxaliplatin- or gemcitabine-based chemotherapy after allocation by standard criteria or by genetic markers in patients with resected pancreatic carcinoma
- Where
- Aachen, Augsburg, Berlin, Bochum, Bonn, Cologne, Deggendorf, Dresden, Erlangen, Frankfurt am Main, Frankfurt Am Main, Freiburg im Breisgau, Goettingen, Halle Saale, Hamburg, Hanover, Heidelberg, Homburg, Jena, Kiel, Leipzig, Luebeck, Mainz, Mannheim, Marburg, Munich, Paderborn, Regensburg, Rostock, Saarbruecken, Ulm, Winnenden, Wuerzburg
- Age
- 18 years and over
- People
- 414 worldwide
- Run by
- Universitaetsklinikum Heidelberg AöR
See details and how to joinNCT05314998EU 2024-514682-19-00Registry updated 2026-10-21
Phase 3Not yet recruitingResearch participation
Phase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
- Where
- Berlin, Bochum, Dresden, Frankfurt am Main, Hamburg, Munich, Ulm
- Age
- 18 years and over
- People
- 233 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2025-524969-24-00EU 2025-524969-24-00Registry updated 2026-10-20
Phase 1/2RecruitingTrial-stage medicine
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Where
- Bochum, Düsseldorf, Frankfurt am Main, Lübeck, München
- Age
- 18 years and over
- People
- 346 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06885034Registry updated 2026-10-19
Phase 2/3Not yet recruitingResearch participation
A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination with Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants with First-Line Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- Dresden, Essen, Hamburg, Ulm
- Age
- 18 years and over
- People
- 194 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2025-522563-15-00EU 2025-522563-15-00Registry updated 2026-10-16
Phase 1/2RecruitingTrial-stage medicine
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Where
- Bochum, München, Ulm
- Age
- 18 years and over
- People
- 245 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07186842EU 2025-522613-26-00Registry updated 2026-10-15
Phase 1RecruitingTrial-stage medicine
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Where
- Berlin, Ulm, Wuerzburg
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06026410EU 2024-513285-19-00Registry updated 2026-10-14
Phase 2/3RecruitingTrial-stage medicine
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Where
- Berlin, Dresden, Düsseldorf, Leipzig, München
- Age
- 18 years and over
- People
- 982 worldwide
- Run by
- Pfizer
See details and how to joinNCT06989437EU 2025-522093-36-00Registry updated 2026-10-14
Phase 1RecruitingTrial-stage medicine
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Where
- Essen
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07261631Registry updated 2026-10-09
Phase 1/2RecruitingTrial-stage medicine
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Bayern, Berlin, Heidelberg, Mainz
- Age
- 18 years to 130 years
- People
- 695 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05417594EU 2023-504984-17-00Registry updated 2026-10-05
Phase 3RecruitingTrial-stage medicine
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Berlin, Bochum, Bonn, Dresden, Frankfurt am Main, Heidelberg, München, Tuebingen, Ulm, Wuerzburg
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07491445EU 2025-525088-34-00Registry updated 2026-10-02
Phase 3RecruitingResearch participation
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Magdeburg
- Age
- 18 years and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00EU 2025-524160-38-00Registry updated 2026-10-01
Phase 1/2RecruitingResearch participation
Phase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Pancreatic Cancer (Substudy PDAC)
- Where
- Berlin, Bochum, Dresden, Frankfurt am Main, Leipzig, Mainz
- Age
- 18 years and over
- People
- 26 worldwide
- Run by
- Merck Healthcare KGaA
See details and how to join2024-517819-74-00EU 2024-517819-74-00Registry updated 2026-09-28
Phase 2RecruitingResearch participation
Using lab-grown mini-tumors from pancreatic cancer tissue to predict and improve post-surgery treatment for pancreatic cancer
- Where
- Berlin, Bochum, Mannheim, Munich, Nuremberg, Tuebingen, Ulm
- Age
- 18 years and over
- People
- 92
- Run by
- Universitaetsklinikum Ulm AöR
See details and how to join2023-510490-34-00EU 2023-510490-34-00Registry updated 2026-09-25
All Pancreatic cancer trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.